EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $97,933 | -3.2% | 3,452 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $101,194 | +4.3% | 3,462 | -5.8% | 0.00% | 0.0% |
Q3 2022 | $97,000 | -43.3% | 3,675 | -4.3% | 0.00% | -66.7% |
Q2 2022 | $171,000 | -20.5% | 3,842 | -11.5% | 0.00% | +50.0% |
Q1 2022 | $215,000 | -4.9% | 4,342 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $226,000 | -16.9% | 4,442 | -9.0% | 0.00% | -33.3% |
Q3 2021 | $272,000 | +30.1% | 4,883 | 0.0% | 0.00% | +50.0% |
Q2 2021 | $209,000 | +2.5% | 4,883 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $204,000 | -8.5% | 4,883 | +2.1% | 0.00% | -33.3% |
Q4 2020 | $223,000 | +29.7% | 4,783 | +17.8% | 0.00% | 0.0% |
Q3 2020 | $172,000 | -11.8% | 4,059 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $195,000 | +4.3% | 4,059 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $187,000 | -23.4% | 4,059 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $244,000 | +1.2% | 4,059 | -4.7% | 0.00% | 0.0% |
Q3 2019 | $241,000 | +3.9% | 4,259 | +2.4% | 0.00% | 0.0% |
Q2 2019 | $232,000 | +7.9% | 4,159 | -2.3% | 0.00% | 0.0% |
Q1 2019 | $215,000 | +28.0% | 4,259 | +1.8% | 0.00% | 0.0% |
Q4 2018 | $168,000 | – | 4,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |